Attention prescribers: be careful with antibiotics

Lancet

Volumn 369, Issue 9560, 2007, Pages 442-443

  Dancer, Stephanie J ^a  

^a SOUTHERN GENERAL HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AZITHROMYCIN; CLARITHROMYCIN; FLUCLOXACILLIN; LINCOSAMIDE; MACROLIDE; MIKAMYCIN B; PENICILLIN G; TETRACYCLINE;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC THERAPY; ARTICLE; DRUG USE; PRESCRIPTION; PRIORITY JOURNAL; STAPHYLOCOCCUS AUREUS; STREPTOCOCCUS PNEUMONIAE;

EID: 33846818670     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(07)60208-6     Document Type: Note

References (13)

1. Malhotra-Kumar S., Lammens C., Coenen S., Van Herk K., and Goossens H. Effect of azithromycin and clarythromycin therapy on pharyngeal carriage of macrolide-resistant streptococci in healthy volunteers: a randomised, double-blind, placebo-controlled study. Lancet 369 (2006) 482-490
2. European Antimicrobial Resistance Surveillance System (EARSS) Annual Report (2004), Rijksinstituut voor Volksgezondheid en Milieu (RIVM), Bilthoven, Netherlands
3. Majeed A., and Wrigley T. Antibiotic prescribing rates in England are falling. BMJ 325 (2002) 340
4. Vardhan M., Allen K., and Bennett E. Antibiotic prescribing and penicillin-resistant pneumococci in a Merseyside Health District. J Infect 46 (2003) 30-34
5. Muller A., Mauny F., Talon D., Donnan P., Harbarth S., and Bertrand X. Effect of individual- and group-level exposure on MRSA isolation: a multilevel analysis. J Antimicrob Chemother 58 (2006) 878-881
6. Schentag J., Hyatt J., Carr J., et al. Genesis of methicillin-resistant Staphylococcus aureus (MRSA), how treatment of MRSA infections has selected for vancomycin-resistant Enterococcus faecium, and the importance of antibiotic management and infection control. Clin Infect Dis 26 (1998) 1204-1214
7. Meyer E., Jonas D., Schwab F., Gastmeier P., Ruden H., and Daschner F. SARI: surveillance of antibiotic use and bacterial resistance in German intensive care units: correlation between antibiotic use and the emergence of resistance. Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz 47 (2004) 345-351
8. MacDougall C., Powell J., Johnson C., Edmond M., and Polk R. Hospital and community fluoroquinolone use and resistance in Staphylococcus aureus and Escherichia coli in 17 US hospitals. Clin Infect Dis 41 (2005) 435-440
9. Goossens H., Ferech M., Vander Stichele R., and Elseviers M. Outpatient antibiotic use in Europe and association with resistance: a cross-national database study. Lancet 365 (2005) 579-587
10. Smith D., Harris A., and Johnson J. Animal antibiotic use has an early but important impact on the emergence of antibiotic resistance in human commensal flora. Proc Natl Acad Sci USA 99 (2002) 6434-6439
11. Kummerer K. Significance of antibiotics in the environment. J Antimicrob Chemother 52 (2003) 5-7
12. Dancer S., Coyne M., Robertson C., Thomson A., Guleri A., and Alcock S. Antibiotic use is associated with resistance of environmental organisms in a teaching hospital. J Hosp Infect 62 (2006) 200-206
13. Dancer S. How antibiotics can make us sick: the less obvious adverse effects of antimicrobial chemotherapy. Lancet Infect Dis 4 (2004) 611-619